Clinical Trials
2 trialsNCT05511428 2025-11-21
Home Based Daratumumab Administration for Patients With Multiple Myeloma
Thomas Jefferson University
Phase 4 Completed
NCT03768960 2025-02-03
A Study of DARZALEX (Daratumumab) In Indian Participants With Relapsed and Refractory Multiple Myeloma, Whose Prior Therapy Included a Proteasome Inhibitor and an Immunomodulatory Agent
Johnson & Johnson Private Limited
Phase 4 Completed